ENZA-p trial

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

July, 2025

ENZA-p trial

Apr 15, 2024, 14:41 | Drugs

Piotr Wysocki: The [177Lu]Lu-PSMA-617 plus enzalutamide combination is active and safe in mCRPC patients, but is it really an option for first-line treatment?

Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…

All: 1 Posts: 1 - 100

'

Garo Armen Shares a Personal Story Driving Agenus' Mission in Cancer Care

'

Dr. Oliver Bogler, PhD: Leaving the National Cancer Institute

'

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care

'

Sibylle Loibl: Final survival Results from the PENELOPE-B trial published in Annals of Oncology

'

Yvonne Awards 2025: Honoring Global Oncology Leaders at ASCO’s Most Inspiring Night

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023